Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 18,227 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 18,227 shares of Retractable Technologies stock in a transaction on Monday, February 3rd. The shares were bought at an average price of $0.77 per share, with a total value of $14,034.79. Following the completion of the transaction, the chief executive officer now directly owns 15,037,535 shares of the company’s stock, valued at $11,578,901.95. This trade represents a 0.12 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Retractable Technologies Stock Up 1.0 %

NYSE:RVP traded up $0.01 during mid-day trading on Tuesday, hitting $0.80. The stock had a trading volume of 23,760 shares, compared to its average volume of 105,113. The stock has a 50-day simple moving average of $0.70 and a two-hundred day simple moving average of $0.80. The company has a market capitalization of $23.86 million, a PE ratio of -1.48 and a beta of 1.96. Retractable Technologies, Inc. has a twelve month low of $0.56 and a twelve month high of $1.34. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research note on Thursday, January 30th. They issued a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.